CLASS II Drug recall · Reported 15 Mar 2017 · FDA Enforcement Report

Aspirin Chewable Tablets, 81 mg, (Nsaid*) recalled

Mckesson Packaging Services is recalling Aspirin Chewable Tablets, 81 mg, (Nsaid*), distributed nationwide in the US. The recall was initiated on 23 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18
Quantity recalled6,717 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0513-2017
FDA event ID
76631
Recalling firm
Mckesson Packaging Services, Concord, NC
Classification
Class II
Status
Completed
Recall initiated
23 Feb 2017
FDA classified
7 Mar 2017
Reported
15 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material
Drug class
Pain Medication

Timeline

23 Feb 2017Recall initiated by company
7 Mar 2017Classified by FDA+12 days
15 Mar 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: foreign material found in the bulk inventory.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: foreign material found in the bulk inventory.

Which lots are affected?

Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mckesson Packaging Services

All 17

Other Aspirin recalls

All 8